Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

Table 1 Radiation treatment parameters

Treatment characteristic	Mean	Per protocol	Minor variations	Major variations
GTV	175 cc
PTV	360 cc
Isodose Line	78%	10	0	0
PTV (V25Gy)	95.5%	10	0	0
Other Bowel (V25Gy)	0.40 cc	10	0	0
Duodenum (V25Gy)	0.78 cc	9	1	0

Mean percent target coverage, prescription isodose line and critical structure dose/volume results and minor and major variations from protocol.

ISSN: 1748-717X